Stephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os
|
|
- Lester Dickerson
- 6 years ago
- Views:
Transcription
1 STD Diagnosis and Treatment Ina Park, MD, MS STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Stephanie 23 year-old female presents for contraception, Pap, and desires IUD placement No complaints; LMP 3 weeks prior New male partner within past month -- they initially used condoms, but stopped using them about 4 weeks ago STD Screening for Women Sexually Active adolescents & up to age 25 Chlamydia and gonorrhea screening (USPSTF grade B recommendation) Others STDs and HIV based on risk Women > 25 years of age STD/HIV testing based on risk Pregnant women Chlamydia Gonorrhea (<25 years of age or risk) HIV Syphilis serology HepB sag Hep C (if high risk) STD Atlas, 1997 Physical Exam Cervix with discharge from os CDC 2010 STD Tx Guidelines 1
2 Cervicitis Diagnosis Diagnostic criteria: Pus from the cervix covers a Q-tip (Q-tip test) OR Cervical friability (easily bleeds when touched) Test for GC and CT Evaluate for PID, BV and trichomonas; consider HSV Cervicitis Treatment Treat for chlamydia: Age 25 or younger STD risk: new/multiple partners, partner with other partners, unprotected sex Follow-up unlikely Treat for gonorrhea: High prevalence (>5%) Treat BV if present CDC 2010 STD Tx Guidelines CDC 2010 STD Tx Guidelines Chlamydia Treatment Adolescents and Adults Stephanie Recommended regimens (non-pregnant): Azithromycin 1 g orally in a single dose Doxycycline 100 mg orally twice daily for 7 days Recommended regimens (pregnant*): Azithromycin 1 g orally in a single dose Amoxicillin 500 mg orally TID x 7 days * Test of cure at 3-4 weeks only in pregnancy No evidence of BV or trich, no findings on pelvic exam Lab tests for GC and CT ordered Prescription for azithromycin 1 gram given 2
3 Stephanie Physical Exam 4 days later, she returns to clinic with RLQ abdominal pain Her prescription was never filled b/c I felt fine and I was busy Lab tests are still pending She has a low grade fever and increased vaginal discharge, External genitalia and glands normal Thin yellow vaginal discharge Cervix is friable with mucopurulent discharge from the os Bimanual exam reveals mild cervical motion tenderness, questionable uterine tenderness PID Diagnosis Minimum Clinical Criteria: Lower abdominal/pelvic pain and one or more of the following: o Uterine tenderness OR o Adnexal tenderness OR o Cervical motion tenderness Pelvic Inflammatory Disease (PID) Ascending infection starting from cervix Can involve the endometrium, fallopian tubes, and pelvic peritoneum Cervical infection may or may not be present at the time of diagnosis Severe PID (4%) Outpatient PID (36%) Subacute PID (60%) CDC 2010 STD Tx Guidelines 3
4 Pelvic Inflammatory Disease Adhesions-Tubal blockage STD Atlas, PID: Oral Treatment Regimens Oral/IM regimens: Ceftriaxone 250 mg IM (or other parenteral 3rd generation cephalosporin) x 1 or Cefoxitin 2 g IM with probenecid 1 g orally once PLUS Doxycycline 100 mg orally twice daily for 14 days WITH OR WITHOUT Metronidazole 500 mg orally twice daily for 14 days PID: Indications for Hospitalization Surgical emergency cannot be excluded Tubo-ovarian abscess Pregnancy Severe illness (nausea, vomiting, high fever) Unable to follow or tolerate outpatient regimen Failure to respond to outpatient therapy CDC 2010 STD Tx Guidelines CDC 2010 STD Tx Guidelines 4
5 PID: Patient Follow-Up Outpatient: re-examine within 72 hours to ensure improvement in symptoms; if not better, place on intravenous therapy Repeat CT/GC testing at 3 months All sex partners within past 60 days need treatment Stephanie No indications for hospitalization Treatment: ceftriaxone + doxy Scheduled f/u in 3 days At the f/u visit, she reported compliance with treatment regimen; symptoms much improved Test results: CT neg, GC neg, HIV neg She reschedules an appt for an IUD and takes a script for a vaginal ring in the meantime Jeremy What STD screening would you offer this patient? 24 Y/O bisexual male presents to clinic for STD check up. No symptoms Reports giving and receiving unprotected oral sex with 4 new male partners during trip to New Orleans ~1 week ago. 1 female partner who does not know that he occasionally has sexual contact with men. A. Syphilis screening B. Urine NAAT for GC/CT C. Pharyngeal NAAT for GC D. Rectal NAAT for GC/CT E. All of the above 2% 6% 1% 2% 88% S y p h i l i s s c r e e n i n g U r i n e N A A T f o r G C / C T P h a r y n g e a l N A A T f o r G C R e c t a l N A A T f o r G C / C T A l l o f t h e a b o v e 5
6 STD Screening for MSM HIV Syphilis Urethral GC and CT Rectal GC and CT (if anal sex) Pharyngeal GC (if oral sex) Hepatitis B (HBsAg) Hepatitis C (if high risk) HSV-2 serology (consider) Anal Pap (consider for HIV+) * At least annually, more frequent (3-6 months) if at high risk (multiple/anonymous partners, drug use, high risk partners) * CDC 2010 STD Tx Guidelines Proportion of MSM* Attending STD Clinics with Primary and Secondary Syphilis, Gonorrhea or Chlamydia by HIV Status, STD Surveillance Network (SSuN), 2011 *MSM=men who have sex with men. Excludes all persons for whom there was no laboratory documentation or self-report of HIV status. GC urethral and CT urethral include results from both urethral and urine specimens Fig Y. SR Proportion of CT/GC MISSED if screening only performed at urethral site (urine), San Francisco, n=3398 patient visits 3 friends with HSV Helen Sylvia Victoria Chlamydia Gonorrhea Among asymptomatic MSM Marcus et al, STD Oct 2011; 38:
7 Clinical Progression of Herpes Lesions Helen was diagnosed with her first outbreak of genital HSV-2. She had multiple large bilateral vulvar ulcers which are at the early healing stage after 3 days Is it too late for me to start treatment for herpes? Early Redness/ Swelling Thin-Walled Fluid- Filled Vesicles and Pustules Early Healing of Vesicles, Erosions, or Ulcers Crusting Scabbing Healed Skin Genital Herpes Treatment 1st Clinical Recurrent Genital Herpes: Episode: Episodic Suppressive (mg for 7-10 days) (mg days) (mg, daily) Acyclovir 400 TID 400 TID x 5 d 400 BID 250 5x/day 800 BID x 5 d 800 TID x 2 d Famciclovir 250 TID 125 BID x 5 d 250 BID* 1000 BID x 1 d 500 mg PO x 1, then 250mg BID x 2 days Valacyclovir 1000 BID 500 BID x 3 d 500 QD 1000 QD x 5 d 1000 QD * Somewhat less effective for suppression of shedding CDC 2010 STD Treatment Guidelines Helen s back I already ran out of the prescription, help! She starts valacyclovir and has taken it for 7 days but she s still not completely healed There is no evidence of cellulitis 7
8 Primary Genital Herpes Incubation period ~ 4 days (2-14 day range) Systemic symptoms in up to 80% Fever, headache, malaise, myalgia Local symptoms pain, itching, dysuria, discharge, inguinal adenopathy Multiple painful lesions develop bilaterally New lesions may appear for up to 10 days, with mean duration of lesions 18 days. Treatment should continue if healing is incomplete after the first course of antivirals ALL first episodes of HSV should be treated Should I go on suppressive therapy? Sylvia was diagnosed with HSV-2 last year. She isn t sexually active right now (has sex with men) and has had 3 outbreaks in the past year, which she treated with episodic acyclovir. Episodic vs Suppressive Therapy Episodic therapy Decreases healing time by 2 days Decreases pain by 1 day Decreases viral shedding by 2 days Suppressive therapy Decreases frequency of recurrences by 70-80% Decreases severity of recurrences Decreases subclinical viral shedding Decreases transmission Management of Patients Consider daily suppressive therapy for: Are bothered by their outbreaks, regardless of their relationship status Are sexually active with an uninfected partner* Are newly diagnosed and concerned about transmitting genital herpes to their partner* Consider episodic therapy for patients who: Are not sexually active and not concerned about their outbreaks Are sexually active with a partner who also has genital herpes * Studied in immunocompetent heterosexual adults 8
9 A. Nearly 100% B % C. About 50% D. Only 25% E. Not sure How effective is suppressive therapy at reducing HSV-2 transmission? N e a r l y % 2% % 53% A b o u t 5 0 % 37% O n l y 2 5 % 5% N o t s u r e 3% Transmission of HSV-2 to Susceptible Partners is Reduced with Once-Daily Suppression 1484 heterosexual couples randomized to 500 mg of valacyclovir vs placebo once daily for 8 months Monthly serum samples collected from susceptible partners Valacyclovir group showed decreased transmission lower frequency of shedding fewer copies of HSV-2 DNA when shedding occurred Percent Transmission % Valacyclovir Group (N=743) 3.6% Control Group (N=741) Corey et al, NEJM 2004; 350(1): Intermittent Suppression Treatment scenarios Reduce risk of episode on special occasions: wedding, vacation, final exam Reduce transmission risk: pregnancy, new sexual relationship To evaluate herpes symptoms or differentiate herpes symptoms from other symptoms Use suppressive therapy dosage indicated for each antiviral agent Treatment must be initiated ~ 5 days in advance of desired event Victoria was diagnosed with HSV-2 2 years ago and had 6 outbreaks her first year. She has been outbreak free on suppressive acyclovir therapy which she has taken continuously for a year. How long can I stay on supression? 9
10 Long-term suppressive therapy Continuous suppresive therapy appears safe Safety data for up to 6 years with continuous acyclovir, 1 year for valacyclovir and famciclovir Check-in once a year to discuss the need to continue. No laboratory monitoring is necessary in a healthy person I feel like I will never date again Fife KH et al. JID 1994 Online dating for patients with herpes We re all pregnant Positivesingles.com Hdate.com Hsvsingles.com Mpwh.com Herpespassions.com Lovewithherpes.com Herpeslove.net STDsoulmates.com Helen Sylvia Victoria 10
11 ACOG Recommendations Offer antivirals for primary outbreak* oral or IV if severe outbreak Offer suppressive therapy women 36 weeks with active recurrent genital HSV (level B) C-section for women with active symptoms or prodromal symptoms at delivery Offer suppressive therapy to reduce transmission in discordant couples + *ACOG practice bulletin No.82, June ACOG practice bulletin No 57, Nov 2004 Brenda 19 year old woman who has sex with both women and men Asymptomatic, no prior STDs STD screening done on intake No known drug allergies GC positive CT negative What regimen would you use to treat Gonorrhea? 1. Cefixime 400 mg PO plus azithromycin 1 gm PO 2. Ceftriaxone 250 mg IM 3. Azithromycin 2 gm PO 4. Ceftriaxone 250 mg IM plus azithromycin 1 gm PO 5. E. Ceftriaxone 125 mg IM plus azithromycin 1gm PO C e f i x i m e m g P O p l u s... 5% C e f t r i a x o n e m g I M 15% A z i t h r o m y c i n 2 g m P O 4% E. C e f t r i a x o n e m g I... C e f t r i a x o n e m g I M p l.. 71% 5% 11
12 Dual Antibiotic Therapy for Gonorrhea (Urogenital, rectal, pharyngeal) Ceftriaxone 250 mg IM in a single dose * Regardless of CT test result PLUS* Azithromycin 1 g orally (preferred) or Doxycycline 100 mg BID x 7 days* CDC 2010 STD Treatment Guidelines Gonorrhea Treatment Alternatives Anogenital Infections ALTERNATIVE CEPHALOSPORINS: Cefixime 400 mg orally once PLUS Dual treatment with azithromycin 1 g (preferred) or doxycycline 100 mg BID x 7 days, regardless of CT IN CASE OF SEVERE ALLERGY: Gentamicin Azithromycin 240 mg 2 IM g + orally azithromycin once 2g PO (Caution: OR GI intolerance, emerging resistance) Gemifloxacin 320 mg orally + azithromycin 2g PO 12
13 EVA 18yo female presents for college PE Vaginal swab NAAT tests positive for chlamydia. She receives appropriate treatment with Azithromycin 1 gm. Chlamydia Treatment Adolescents and Adults Recommended regimens (non-pregnant): Azithromycin 1 g orally in a single dose Doxycycline 100 mg orally twice daily for 7 days Recommended regimens (pregnant*): Azithromycin 1 g orally in a single dose Amoxicillin 500 mg orally TID x 7 days * Test of cure at 3-4 weeks only in pregnancy When should she return for followup after chlamydia treatment? Repeat Infection is Dangerous A. A. One week for test of cure B. B. Three weeks for test of cure C. C. Three months for retesting D. D. One year for annual exam 2% A. O n e w e e k f o r t e s t o f c u r e B. T h r e e w e e k s f o r t e s t o f... C. T h r e e m o n t h s f o r r e t e s... 74% 18% 6% D. O n e y e a r f o r a n n u a l... Repeat CT infection leads to higher risk of complications: PID, ectopic pregnancy, infertility Most infections are asymptomatic Relative Risk st Infection 2nd Infection 3rd Infection Pelvic Inflammatory Disease Ectopic Pregnancy Hillis SD, et al. (1997). Am J Obstet Gynecol 176(1 Pt 1):
14 Current Retesting Recommendations All individuals (male and female) with CT or GC should be retested ~ 3 months after initial treatment Retesting should occur whenever patient returns to clinic anytime within 1-12 months post treatment Test of cure at 3 weeks for CT is only recommended routinely for pregnant women CDC 2010 STD Tx Guidelines, Want to know more about STDs? There s an app for that. CDC Treatment Guidelines App for Apple and Android Available now, FREE! ( STD Tx ) Download the app now Need advice from an STD expert? Contact us! Clinician Warmline stdcb@cdph.ca.gov 14
15 Thank you!! Contact information 15
Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.
Disclosures Management of STIs: Challenges in Practice I have no disclosures or conflicts of interest to report. Alison O. Marshall, MSN, FNP-C Associate Professor of Practice & Director of the Family
More informationCategories of STI Screening and Testing Routine screening Population based risk factors Targeted screening Personal behavioral risk factors Contact te
Sexually Transmitted Infections: New Tests, New Guidelines Michael S. Policar, MD, MPH UCSF Ob, Gyn, and Reproductive Sciences No disclosures for this lecture Value of STI Screening and Testing Benefits
More informationSexually Transmitted Infections: New Tests, New Guidelines
Sexually Transmitted Infections: New Tests, New Guidelines Michael S. Policar, MD, MPH UCSF Ob, Gyn, and Reproductive Sciences No disclosures for this lecture Value of STI Screening and Testing Benefits
More informationGenital Herpes Infections
Genital Herpes Infections Clinical Guidelines and Consultation Linda Creegan, MS, FNP California STD/HIV Prevention Training Center Linda.creegan@ucsf.edu www.cdc.gov/std/treatment/ www.std.ca.gov Clinician
More informationDisclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None
Disclosures None What s New in the 2015 CDC STD Treatment Guidelines Ina Park, MD, MS California STD/HIV Prevention Training Center UCSF Dept of Family and Community Medicine STD Control Branch California
More informationSexually Transmitted Diseases
Sexually Transmitted Diseases Ina Park, MD, MS California Prevention Training Center University of California San Francisco Dept of Family and Community Medicine Disclosures/Disclaimers No disclosures
More informationAnswers to those burning questions -
Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department
More informationINTRAUTERINE DEVICES AND INFECTIONS. Tips for Evaluation and Management
INTRAUTERINE DEVICES AND INFECTIONS Tips for Evaluation and Management Objectives At the end of this presentation, the participant should be able to: 1. Diagnose infection after IUD placement 2. Provide
More informationCLINICAL MANAGEMENT OF STDS
CLINICAL MANAGEMENT OF STDS Diana Torres-Burgos MD, MPH NYC STD/HIV Prevention Training Center STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline Essential components of STD care management Sexual
More informationDisclosure Information Julie Stoltey, MD MPH
Courtesy CDC Public Health Image Library The New Yorker 2012 2016 Update on Testing, Treatment, and Gonorrhea Resistance Julie Stoltey, MD, MPH STD Control Branch-California Dept. of Public Health Assistant
More informationClinical Practice Objectives
STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public
More informationSTD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH
STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures
More informationSexually Transmitted Diseases. Summary of CDC Treatment Guidelines
DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.
More informationNothing to disclose.
Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence
More informationClinical Cases from the STD Clinical Consultation Network
Clinical Cases from the STD Clinical Consultation Network Christine Johnston STD TCG April 24, 2017 Last Updated: uwptc@uw.edu uwptc.org 206-685-9850 STD Clinical Consultation Network (STDCCN) Developed
More informationOverview. Disclosures. Sexually Transmitted Diseases: What s New in the Guidelines and Beyond?
Sexually Transmitted Diseases: What s New in the Guidelines and Beyond? Susan S. Philip, MD, MPH Director, Disease Prevention and Control Branch Population Health Division San Francisco Department of Public
More informationNew Guidelines for Detection and Treatment of Sexually Transmitted Infections
UCSF Controversies in Women s health December 8, 2016 San Francisco, CA New Guidelines for Detection and Treatment of Sexually Transmitted Infections Disclosure I am a litigation consultant to a law firm
More informationThe (likely) New 2010 CDC STD Treatment Guidelines Guideline Development Process. Overview
The (likely) New 2010 CDC STD Treatment Guidelines http://www.cdc.gov/std/treatment Deborah Cohan, MD, MPH University of California, San Francisco San Francisco General Hospital cohand@obgyn.ucsf.edu I
More informationUpdate on Sexual Health: Screening, Diagnosing and Treating STIs
Update on Sexual Health: Screening, Diagnosing and Treating STIs Dr Gila Metz Medical Director, Health Sexuality and Risk Reduction Unit Ottawa Public Health November 28, 2013 Objectives To review current
More informationRETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance
RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance Ina Park, MD, MS University of California San Francisco California Prevention Training Center DISCLOSURE No Relevant
More informationCASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY
MHD II, Session 6, STUDENT Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6 Friday, MARCH 18, 2016 STUDENT COPY Resource for cases: ACP Medicine (Scientific American Medicine) - Vaginitis
More informationSTDs and Hepatitis C
STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk
More informationX-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers
X-Treme Primary Care: HPV and STIs Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers Learning Objectives Review recommendations for HPV related cancer screening in
More informationBiology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s)
Biology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s) STI s once called venereal diseases More than 20 STIs have now been identified most prevalent among teenagers and young adults.
More informationS403- Update on STIs for the Generalists
S403- Update on STIs for the Generalists Mobeen H. Rathore, MD Professor and Director University of Florida Center for HIV/AIDS Research Education and Service (UF CARES) Chief, Pediatric Infectious Diseases
More informationPELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID) DEFINITION Pelvic inflammatory disease is an infection of the female upper genital tract that involves any combination of the uterus, endometrium, ovaries, fallopian tubes,
More informationALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis
More informationSexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System
Sexually Transmitted Infections in the Adolescent Population Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System STI in the Adolescent High school students nationwide, 34.2% were
More informationSTI Indicators by STI
STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationSyphilis: Screening (USPSFT) Syphilis: Screening. Sexually Transmitted Diseases. Family Medicine Board Review Course. Reference
Sexually Transmitted Diseases Family Medicine Board Review Course March 26, 2012 Ronald H. Goldschmidt, MD Reference Centers for Disease Control and Prevention Guidelines for Treatment of Sexually Transmitted
More informationSTI 2016: Where We Need to Go
STI 2016: Where We Need to Go Gail Bolan, M.D. Director, Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and Prevention Sexually
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More informationCASE-BASED SMALL GROUP DISCUSSION MHD II SESSION VI. Friday, MARCH 20, 2015 STUDENT COPY
MHD II, Session VI, STUDENT Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION VI Friday, MARCH 20, 2015 STUDENT COPY Resource for cases: ACP Medicine (Scientific American Medicine) - Vaginitis
More informationCase 1. Case 1. Physical exam
11/13/2012 Case 28 year-old woman Complains of very painful lesions in vulvar area Increasing severity since 4 days Pain aggravated by urination She has a slight fever and also complains of headache and
More informationGynaecology. Pelvic inflammatory disesase
Gynaecology د.شيماءعبداألميرالجميلي Pelvic inflammatory disesase Pelvic inflammatory disease (PID) is usually the result of infection ascending from the endocervix causing endometritis, salpingitis, parametritis,
More informationUpdate on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH
Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH Division of Infectious Diseases University of Alabama at Birmingham School of Medicine Birmingham, Alabama Outline Syphilis in all its
More informationQuick Study: Sexually Transmitted Infections
Quick Study: Sexually Transmitted Infections Gonorrhea What is it: A bacterial infection of the genitals, anus, or throat. How common: The CDC estimates 820,000 people in the United States get Gonorrhea
More informationSTD Prevention Among Youth
STD Prevention Among Youth Jody Pierce Glover New Beginnings Emer S. Smith, MPH Maine Center for Disease Control & Prevention In Today s Talk... Maine Learning Results: Education Content Areas Health Behaviors
More information5/1/2017. Sexually Transmitted Diseases Burning Questions
Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial
More informationChapter 11. Sexually Transmitted Diseases
Chapter 11. Sexually Transmitted Diseases General Guidelines Persons identified as having one sexually transmitted disease (STD) are at risk for others and should be screened as appropriate. Partners of
More informationShelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annual more than 1.5 million
More informationGenital Tract Infections in Women. Michael S. Policar, MD, MPH UCSF School of Medicine
Genital Tract Infections in Women Michael S. Policar, MD, MPH UCSF School of Medicine www.policarlectures.com Value of STI Screening and Testing Benefits Detect infection Patient treatment Partner treatment
More informationSexually Transmitted Infections Angela Farrell MD Dept of Family Medicine University of Iowa
Sexually Transmitted Infections Angela Farrell MD Dept of Family Medicine University of Iowa Objectives Review taking a sexual history Discuss screening, diagnosis, and management of chlamydia, gonorrhea,
More informationSTD UPDATE 2017 FSACOFP CONVENTION
STD UPDATE 2017 FSACOFP CONVENTION L. Michael Waters, Jr, DO Adjunct Clinical Assistant Professor of Family Medicine LECOM-Bradenton Clinical Assistant Professor of Family Medicine PCOM- Georgia DISCLOSURES
More informationUpdate on Sexually Transmitted Infections among Persons Living with HIV
Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases Abbreviations and
More informationTimby/Smith: Introductory Medical-Surgical Nursing, 9/e
Timby/Smith: Introductory Medical-Surgical Nursing, 9/e Chapter 62: Caring for Clients With Sexually Transmitted Diseases Slide 1 Epidemiology Introduction Study of the occurrence, distribution, and causes
More informationJulie Nelson RNC/WHNP-BC Epidemiology NURS 6313
Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313 Chlamydia Most frequently reported bacterial STI in the US In 2006, In U.S. 1,030,911 cases were reported. Estimated 2,291,000 infections in 14-39 year olds.
More informationSTI Review. CALM: STI/HIV - Lesson One (Handout 3) Bacteria/ Transmission. Symptoms. Disease. Virus
STI Review Bacteria/ Virus? Transmission Chlamydia Bacteria Unprotected vaginal or anal sex with a person who has Chlamydia Genital Herpes Virus By direct contact with the sores or blisters of an infected
More informationThe Impact of Sexually Transmitted Diseases(STD) on Women
The Impact of Sexually Transmitted Diseases(STD) on Women GAL Community Symposium AUM September 2, 2011 Agnes Oberkor, MPH, MSN, CRNP, Nurse Practitioner Senior Alabama Department of Public Health STD
More informationSummary Guidelines for the Use of Herpes Simplex Virus (HSV) Type 2 Serologies
Summary Guidelines for the Use of Herpes Simplex Virus (HSV) Type 2 Serologies Genital herpes is one of the most prevalent sexually transmitted diseases, affecting more than one in five sexually active
More informationBursting Pelvic Inflammatory Disease.
www.infertiltysolutionsng.info/blog Disclaimer The information in this book is provided for educational purposes only and is not intended to treat, diagnose or prevent any disease. The information in this
More informationSexually Transmitted Disease Treatment Tables
Sexually Transmitted Disease Treatment Tables Federal Bureau of Prisons Clinical Practice Guidelines June 2011 Clinical guidelines are made available to the public for informational purposes only. The
More informationDrugs for UTIs and STDs. Dr.Vishaal Bhat Associate Professor MMMC Manipal
Drugs for UTIs and STDs Dr.Vishaal Bhat Associate Professor MMMC Manipal Classification of UTI s Clinical: Asymptomatic (98%) Symptomatic (1-2%) Anatomical: Lower tract dis: asymptomatic bacteriuria and
More informationHow is it transferred?
STI s What is a STI? It is a contagious infection that is transferred from one person to another through sexual intercourse or other sexually- related behaviors. How is it transferred? The organisms live
More informationWhat's the problem? - click where appropriate.
STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female
More informationServices for GLBTQ Youth
Sexual Health Care Services for GLBTQ Youth Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Commissioner of Health Buffalo, NY Agenda Introduction Epidemiology Sexual health care services for YMSM Sexual
More informationBursting Pelvic Inflammatory Disease.
www.infertiltysolutionsng.info/blog Disclaimer The information in this book is provided for educational purposes only and is not intended to treat, diagnose or prevent any disease. The information in this
More informationKhalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014
Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine April 2, 2014 E-mail your questions for the presenter to: maphtc@jhsph.edu DISCLOSURES OFF- LABEL USES
More informationPelvic Inflammatory Disease (PID) Max Brinsmead PhD FRANZCOG July 2011
Pelvic Inflammatory Disease (PID) Max Brinsmead PhD FRANZCOG July 2011 This talk What is Pelvic Inflammatory Disease? Why it is important How it is spread Diagnosis Treatment Prevention What is PID? Inflammation
More informationtoe... Chlamydia - CDC Fact Sheet Appendix K - Part 2
Appendix K - Part 2 Chlamydia - CDC Fact Sheet What is chlamydia? Chlamydia is a common STD that can infect both men and women. It can cause serious, permanent damage to a woman's reproductive system,
More informationTO DECREASE THE CHANCE OF GETTING
POST ASSAULT MEDICATIONS Terri Stewart RN Naomi Sugar MD TO DECREASE THE CHANCE OF GETTING Pregnant STDs Chlamydia Gonorrhea Trichomonas Hep B HIV EMERGENCY CONTRACEPTION Plan B Levonorgestrel PLAN B Plan
More informationExtragenital Gonorrhea and Chlamydia among MSM
Extragenital Gonorrhea and Chlamydia among MSM Laura Quilter, MD Infectious Disease and STD PTC Fellow University of Washington Division of Allergy and Infectious Diseases 3/28/2016 uwptc@uw.edu uwptc.org
More informationHow to Prevent Sexually Transmitted Diseases
ACOG publications are protected by copyright and all rights are reserved. ACOG publications may not be reproduced in any form or by any means without written permission from the copyright owner. This includes
More informationSexually Transmitted Infections in the ER. Sahand Ensafi, CCPA University Health Network
Sexually Transmitted Infections in the ER Sahand Ensafi, CCPA University Health Network WARNING This presentation will contain numerous grotesque images of genitalia. Viewer discretion is advised. No disclosures
More informationSexually Transmitted Infections
Sexually Transmitted Infections Christine Hogan M.D. Sexually Transmitted Pathogens Bacteria Neisseria gonorrhoeae Chlamydia trachomatis Mycoplasma genitalium Ureaplasma urealyticum Treponema pallidum
More information2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE
2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE Gale R. Burstein, MD, MPH, FAAP, FSAHM Commissioner, Erie County Department of Health, Clinical Professor of Pediatrics, SUNY at Buffalo School
More informationLove Bugs and Drugs Managing Sexually Transmitted Infections in Teens. Renée R. Jenkins, M.D., F.A.A.P. Howard University College of Medicine
Love Bugs and Drugs Managing Sexually Transmitted Infections in Teens Renée R. Jenkins, M.D., F.A.A.P. Howard University College of Medicine 37 th Annual Sanford Black Hills Pediatric Symposium June 26,
More informationUniversity Health Services at CMU STI Awareness Month specials for students:
University Health Services at CMU STI Awareness Month specials for students: -Free condoms during April (10 per student) -Free walk-in rapid HIV testing April 22-27 (no appointment needed) -STI Screening
More informationBest Practices in STD Partner Management
Best Practices in STD Partner Management An Overview of Patient-Delivered Partner Therapy (PDPT) and Counseling for Partner Notification and Treatment Amber Eisenmann, MS Director of Learning Exchange
More informationWhat Bugs You? A Sexually Transmitted Infection Review
What Bugs You? A Sexually Transmitted Infection Review KATIE DESIMONE, PHARM.D. Disclosures I have no financial affiliations with any of the products or therapies discussed in this presentation Objectives
More informationTrends in STDs: US Perspective. Michael Towns, M.D. WW Vice President, Medical Affairs BD Diagnostic Systems
Trends in STDs: US Perspective Michael Towns, M.D. WW Vice President, Medical Affairs BD Diagnostic Systems Outline Overview of STD Epidemiology and Current Situation in US Overview of Chlamydia infections
More informationHot Topics in STIs. Melanie Deal, MS, FNP-BC University of California Berkeley-Tang Center California Prevention Training Center
Hot Topics in STIs Melanie Deal, MS, FNP-BC University of California Berkeley-Tang Center California Prevention Training Center Ina Park, MD, MS California Prevention Training Center STD Control Branch
More informationOverview. Disclosures. Sexually Transmitted Diseases: Key Clinical Information for 2017
Sexually Transmitted Diseases: Key Clinical Information for 2017 Susan S. Philip, MD, MPH Director, Disease Prevention and Control Branch Population Health Division San Francisco Department of Public Health
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationSay Ahhh!, STDs in Maine. Emer Smith, Maine CDC,
Say Ahhh!, STDs in Maine Emer Smith, Maine CDC, emer.smith@maine.gov Say AHHH! : STDs in Maine Emer S. Smith, MPH Maine Center for Disease Control & Prevention HIV, STD, & Viral Hepatitis Program April
More informationPopulation attributable fraction of genital inflammation and ulceration in HIV risk among discordant couples, Zambia,
Population attributable fraction of genital inflammation and ulceration in HIV risk among discordant couples, Zambia, 1994-2012 10 th International Workshop on HIV Transmission Kristin M. Wall, PhD kmwall@emory.edu
More informationNovos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]
Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB
More informationSexually Transmitted Diseases
Table of content Sexually Transmitted Diseases Judith A. Lightfoot DO, FACOI Update on the prevalence of STD s in the US Which populations are greatly affected? Should we be alarmed? How does this affect
More informationThe objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More informationHOT OFF THE PRESS! R.
STI Update 2016: New CDC Treatment Guidelines Focus on the Female HOT OFF THE PRESS! R. Mimi Secor, DNP, FNP-BC, FAANP Onset, Massachusetts Mimi Secor, DNP, FNP-BC, FAANP Nurse Practitioner for 40 years
More information6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationGENITAL HERPES. 81.1% of HSV-2 infections are asymptomatic or unrecognized. Figure 14 HSV-2 seroprevalence among persons aged years by sex.
GENITAL HERPES Genital herpes is a chronic, lifelong, sexually transmitted disease caused by herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). HSV-1 typically causes small, painful, fluid-filled,
More informationManagement of Gonorrhea in Adolescents and Adults in the United States
SUPPLEMENT ARTICLE Management of Gonorrhea in Adolescents and Adults in the United States Sarah Kidd 1 and Kimberly A. Workowski 1,2 1 Division of STD Prevention, Centers for Disease Control and Prevention,
More information20. VAGINITIS AND SEXUALLY TRANSMITTED DISEASES 5. Allison L. Diamant, MD, MSPH, and Eve Kerr, MD, MPH
20. VAGINITIS AND SEXUALLY TRANSMITTED DISEASES 5 Allison L. Diamant, MD, MSPH, and Eve Kerr, MD, MPH The approach to developing quality indicators for vulvovaginitis and sexually transmitted diseases
More informationBest practices in chlamydia (CT) and gonorrhea (GC) screening in a changing healthcare environment:
Best practices in chlamydia (CT) and gonorrhea (GC) screening in a changing healthcare environment: Lessons from the Infertility Prevention Project (IPP) Goldenkranz Salomon S., Fine D., Curtiss J., Nakatsukasa-Ono
More informationSEXUALLY TRANSMITTED DISEASES (INFECTIONS)
SEXUALLY TRANSMITTED DISEASES (INFECTIONS) HIV/AIDS - TRANSMISSION Sexual intercourse Anal, oral, & vaginal Multiple partners Sharing needles Mother to infant Born or breast milk Blood transfusions Open
More information5/12/11. STI s in Adolescents: Exposing the Hidden Epidemic. Why the hidden epidemic?
STI s in Adolescents: Exposing the Hidden Epidemic Youth and Sexually Transmitted Infections 2011 Mary-Ann Shafer, MD Professor & Vice Chair Department of Pediatrics Division of Adolescent Medicine University
More informationInformation for Informed Consent for Insertion of a Mirena IUD
Information for Informed Consent for Insertion of a Mirena IUD What is an IUD (intrauterine Device)? An intrauterine device (IUD) is a plastic device that is placed into your uterus to prevent pregnancy.
More informationSTIs in Women. *Top 10* STI Highlights. Karen. External genitalia
Artist: Kathryn Love STIs in Women Heidi M. Bauer, MD MPH California Dept of Public Health STD Control California STD/HIV Prevention Training Center UCSF Primary Care Medicine October 3, 28 *Top 1* STI
More information25/02/2016. New onset low abdominal pain in women of reproductive age. New onset low abdominal pain: why it matters?
New onset in women of reproductive age Dr Deborah Bateson Medical Director Family Planning NSW Chair Australasian Sexual Health Alliance why it matters? Can be fatal (consider ectopic pregnancy in all
More informationWelcome to: Coding Scenarios for STD Clinic Visits. We will begin in a few minutes. There will be no sound until the webinar starts.
Welcome to: Coding Scenarios for STD Clinic Visits We will begin in a few minutes. There will be no sound until the webinar starts. Welcome to: Coding Scenarios for STD Clinic Visits You are using audio
More information2/17/2017. Sexually Transmitted Diseases in Children: Is it Abuse? General Considerations. Judy Guinn, MD WI CAN Educational Series February 17, 2017
Sexually Transmitted Diseases in Children: Is it Abuse? Judy Guinn, MD WI CAN Educational Series February 17, 2017 Disclosure Information for: Judy Guinn, MD Sexually Transmitted Diseases in Children:
More informationSexually Transmitted Infections. Kim Dawson October 2010
Sexually Transmitted Infections Kim Dawson October 2010 Objectives: You will learn about: Sexually Transmitted Infections (STI s). How they are transferred. High risk behavior. The most common STI s. How
More informationGenital Herpes in the STD Clinic
Genital Herpes in the STD Clinic Christine Johnston, MD, MPH Last Updated: 5/23/2016 uwptc@uw.edu uwptc.org 206-685-9850 Importance of HSV HSV is the leading cause of GUD - HSV is very common HSV-2: 16%
More informationSexually Transmitted Diseases: Overview
Sexually Transmitted Diseases: Overview Q: What is a sexually transmitted disease (STD)? A: It is an infection or disease passed from person to person through sexual contact. Q: How many people have STDs?
More informationPartner Counseling and Referral Services
Partner Counseling and Referral Services Presented at the Sexually Transmitted Disease (STD) Intensive Course Cleveland, OH June 22, 2012 Rhiannon Richman, MPH Infertility Prevention Project Coordinator
More informationTrends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017
Trends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017 1 Speaker Disclosure Dr. Woo has disclosed that she has no
More informationLearning Objectives. STI Update. Case 1 6/1/2016
Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe
More informationSEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS
SEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS Sarah Garwood MD, Assistant Professor of Pediatrics, Washington University Elizabeth Fox MD, Pediatric Resident, St Louis Children s Hospital STDS IN ADOLESCENTS
More information